Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Data solutionsForge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Index solutionsForge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Forge Thematic BasketsExplore focused views into key private market themesLiquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Data solutions
Index solutions
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (2)
More (2)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Post-Money Valuation
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
NusanoHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$449.68MMSeries D-14/21/2026$155MM$630.01MM$1.25Undisclosed Investors
Rénibus TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$148.41MMSeries B7/17/2025$90MM$238.38MM$3.06Undisclosed Investors
Kumquat BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$135.92MMSeries A-27/28/2021$30MM$494.98MM$10.32Undisclosed Investors
Seaport TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$330.1MMSeries B10/21/2024$226MM$725.46MM$14.92General Atlantic, T. Rowe Price Associates, Foresite Capital, Invus, Goldman Sachs, CPP Investments, ARCH Venture Partners, Sofinnova Investments, Third Rock Ventures, PureTech Health
Ultima GenomicsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Affinia TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$219.17MMSeries C10/7/2025$40MM$156.61MM$1.62New Enterprise Associates, Eli Lilly, Alexandria Venture Investments, Atlas Venture, Avidity Partners, F-Prime Capital, GV, Mass General Brigham Ventures, Perceptive Advisors
Alloy TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$176.24MMSeries E-14/15/2026$30MM$1B$26.178VC, JIC Venture Growth Investments, Echo Capital, Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, Ulysses Diversified Holdings
AlzheonHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$371.22MMSeries E6/12/2024$100MM$1.25B$62.71Alerce Medical Technology Partners
Scorpion TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$1.02BSeries C-27/16/2024$24.31MM$821.83MM$2.54Frazier Life Sciences, Lightspeed Venture Partners, Willett Advisors, Omega Funds, Vida Ventures, Atlas Venture, Abingworth, Fidelity, Boxer Capital, EcoR1 Capital, Surveyor Capital, Invus, Wellington Management, Nextech Invest, OrbiMed, Logos Capital, Woodline Partners LP, Casdin Capital
Tome BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$245.57MMSeries B12/12/2023$150MM$435.54MM$3.03Andreessen Horowitz, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments
Twin HealthHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$304.72MMSeries E8/21/2025$53MM$950MM$13.85Maj Invest, Temasek, ICONIQ Growth
Upstream BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$800MMSeries B6/8/2023$200MM$676.16MM$17.00Enavate Sciences, Venrock Healthcare Capital Partners, Bain Capital Life Sciences, Wellington Management, OrbiMed, Access Biotechnology, Decheng Capital, Altshuler Shaham Provident Funds Ltd., TCG X, HBM Healthcare Investments, Omega Funds, Samsara BioCapital
ArsenalBioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$2.44BSeries C9/4/2024$327.5MM$1.66B$18.58ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVIDIA, Luma Group, T. Rowe Price Associates, Rock Springs Capital, Parker Institute for Cancer Immunotherapy, SoftBank, Bristol-Myers Squibb, Westlake Village BioPartners, Kleiner Perkins, Byers Capital, Hitachi Ventures
Chroma MedicineHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$262MMSeries B3/1/2023$135MM$450.56MM$2.60ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, Alexandria Venture Investments, Atlas Venture, Casdin Vapital, Cormorant Asset Management, Janus Henderson Investors, Newpath Partners, Omega Funds, Osage University Partners, Sofinnova Partners, T Rowe Price, Wellington Management
Cognito TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Hexagon BioHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$194.66MMSeries B2/13/2023$77.3MM$338.5MM$4.23The Column Group, Two Sigma Ventures, 8VC, Nextech Invest, CPP Investments, ATEL Ventures
Inceptive NucleicsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$120MMSeries A9/20/2023$100MM$476.75MM$14.24NVIDIA, Andreessen Horowitz, Obvious Venture, Section 32
AiTAHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$25.63MMSeries C1/14/2025$10MM$317.19MM$5.05Undisclosed Investors
Biosplice TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Convergent TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$130MMSeries A-49/24/2024$40MM$269.38MM$2.01Novo Holdings
Cour Pharmaceuticals DevelopmentHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Genesis Molecular AIHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$340.28MMSeries B-35/20/2026$40MM$806.79MM$9.33Incyte
Hemab TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
Hummingbird BioscienceHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available------Not available----------
49-72 of 471

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.